Journal profile · Medicine, General & Internal
Current Medical Research and Opinion
ISSN 0300-7995 · eISSN 1473-4877 · Taylor and Francis Ltd. · ENGLAND · Monthly · Founded 1972
Current Medical Research and Opinion: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.81; hybrid open access; median 98 days to acceptance (94 articles, last 24 months); community-reported acceptance: easy; 220 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current Medical Research and Opinion is published by Taylor and Francis Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins and Blood Pressure and Hypertension Studies, together about 21.5% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Aims and scopeJournal metrics Editorial board Current Medical Research and Opinion (CMRO) is a MEDLINE-indexed, international journal that publishes research focused on new and existing drugs and therapies, best practices in patient care, developments in diagnostic medicine and medical technology, and innovations in medical and scientific publishing. The journal aims to be a platform for high-quality, ethically sound clinical research, as well as provide a forum for guidance on effective and transparent publication and communication of medical research. CMRO welcomes clinically relevant original research and reviews, brief reports, case series, and commentaries across all therapy areas, especially research pertaining to efficacy, equivalence, and safety. The journal also publishes research applicable to standards and practices in medical and scientific publishing. Pharmacoeconomic studies are considered if there is clear clinical relevance. Letters to the Editor and editorials should discuss articles previously published in CMRO. Please note that CMRO does not publish Phase I, pre-clinical, and/or animal studies. CMRO is committed to ensuring the accessibility and readability of medical and scientific literature. The journal encourages submission of plain language summaries, graphical and video abstracts, and infographics. Please see the Instructions for Authors for more information. All manuscripts submitted to the journal are assessed for suitability by the Executive Editor; then peer-reviewed in a single-anonymized fashion. If you would like to send a pre-submission enquiry regarding your manuscript’s suitability for publication, please contact CMRO’s Executive Editor, Dr. Mithi Ahmed. Authors can publish gold open access in this journal and may choose to publish using our Accelerated Publication services. Read full aims and scope
From the journal's Aims & Scope
Research area (LetPub): Medicine, General & Internal
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes Treatment and ManagementMedicine8.3%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine7.2%
- Blood Pressure and Hypertension StudiesMedicine6%
- Lipoproteins and Cardiovascular HealthMedicine6%
- Inflammatory mediators and NSAID effectsMedicine5.5%
- Diabetes Management and ResearchMedicine5.5%
- Asthma and respiratory diseasesMedicine5.4%
- Medication Adherence and ComplianceMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.81LetPub ·
- CiteScore 2026-06
- 4.4LetPub ·
- SJR 2026-06
- 0.83LetPub ·
- SNIP 2026-06
- 0.84LetPub ·
- h-index
- 98LetPub ·
- h-index
- 148OpenAlex ·
- i10-index
- 4,566OpenAlex ·
- 2-year mean citedness
- 3.12OpenAlex ·
- Self-citation rate
- 3.6%LetPub ·
- Share of gold OA articles
- 10.13%LetPub ·
Volume
- Articles per year
- 173LetPub ·
Articles by year OpenAlex count · 8,353 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 137 | 70 | 24 |
| 2025 | 220 | 144 | 405 |
| 2024 | 228 | 124 | 1,396 |
| 2023 | 203 | 113 | 1,608 |
| 2022 | 251 | 144 | 2,536 |
| 2021 | 257 | 150 | 3,537 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
98 daysMedian, submission to acceptance · P25–P75 72 days – 125 days
- Acceptance to online
- median 14 days (94 articles)
- Submission to online
- median 113 days
- Sample
- 94 articles with submission and acceptance dates (415 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open access
Overview Open journals Open Select Dove Medical Press F1000Research
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor and Francis Ltd.
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1972
- ISSN
- 0300-7995
- Electronic ISSN
- 1473-4877
- Latest issue on the website
- Volume 42, Issue 6 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Current Medical Research and Opinion
What CAS zone is Current Medical Research and Opinion in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Medical Research and Opinion is in Zone 4 of Medicine, and in Zone 3 of the minor category Medicine, General & Internal / Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Medical Research and Opinion?
The latest impact factor listed by LetPub is 2.81; CiteScore 4.4, h-index 148.
How long does peer review take at Current Medical Research and Opinion?
Based on the dates recorded on 94 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 98 days (interquartile range 72–125 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Current Medical Research and Opinion?
According to LetPub and DOAJ records, Current Medical Research and Opinion is indexed in SCIE and Scopus. The journal's website also lists MEDLINE; that list has not been checked against each database.
Is Current Medical Research and Opinion open access, and what is the APC?
Current Medical Research and Opinion is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .